The biological significance of histone modifiers in multiple myeloma: clinical applications (vol 11, 165, 2021)

被引：1
|
作者：
Ohguchi, Hiroto
Hideshima, Teru
Anderson, Kenneth C.
机构：
[1] Harvard Medical School,Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana
[2] Kumamoto University,Farber Cancer Institute
来源：
BLOOD CANCER JOURNAL | 2021年 / 11卷 / 10期
关键词：
D O I：
10.1038/s41408-021-00559-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] The Clinical Significance of Light Chain Predominant Multiple Myeloma
    Arinze, Nkechi
    Singh, Gurmukh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S10 - S10
  • [22] The Clinical Significance of a Novel microRNA Signature in Multiple Myeloma
    Artemaki, Pinelopi I.
    Papanota, Aristea-Maria
    Karousi, Paraskevi
    Liacos, Christine
    Kontos, Christos K.
    Patseas, Dimitris
    Papadimitriou, Maria-Alexandra
    Eleutherakis-Papaiakovou, Evangelos
    Avgeris, Margaritis
    Kanellias, Nikolaos
    Bagratuni, Tina
    Roussou, Maria
    Dialoupi, Ioanna
    Kastritis, Eftathios
    Gavriatopoulou, Maria
    Dimopoulos, Meletios A.
    Scorilas, Andreas
    Terpos, Evangelos
    BLOOD, 2019, 134
  • [23] Clinical significance of serum osteopontin in patients with multiple myeloma
    Kang, So Young
    Lee, Jae Jin
    Lee, Woo In
    KOREAN JOURNAL OF LABORATORY MEDICINE, 2007, 27 (06): : 400 - 405
  • [24] Expression and clinical significance of β-catenin in multiple myeloma.
    Li, Juan
    Zhang, Dian-Bao
    Luo, Shao-kai
    Zhao, Ying
    Huang, Bei-Hui
    Gu, Jing-Li
    BLOOD, 2006, 108 (11) : 341B - 341B
  • [25] The expression and clinical significance of survivin in multiple myeloma.
    Li, J
    Zhao, Y
    Zhang, DB
    Haung, BH
    BLOOD, 2005, 106 (11) : 348B - 348B
  • [26] Clinical significance of interleukin-22 in multiple myeloma
    Tsirakis, George
    Pappa, Constantina A.
    Kolovou, Anna
    Kokonozaki, Maria
    Neonakis, Ioannis
    Alexandrakis, Michael G.
    HEMATOLOGY, 2015, 20 (03) : 143 - 147
  • [27] Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma
    Fonseca, R
    Hoyer, JD
    Aguayo, P
    Jalal, SM
    Ahmann, GJ
    Rajkumar, SV
    Witzig, TE
    Lacy, MQ
    Dispenzieri, A
    Gertz, MA
    Kyle, RA
    Greipp, PR
    LEUKEMIA & LYMPHOMA, 1999, 35 (5-6) : 599 - 605
  • [28] The Emerging Role of Extracellular Vesicle-Associated RNAs in the Multiple Myeloma Microenvironment (vol 11, 689538, 2021)
    Khalife, J.
    Sanchez, J. F.
    Pichiorri, F.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Advances in biology of multiple myeloma: clinical applications
    Hideshima, T
    Bergsagel, PL
    Kuehl, WM
    Anderson, KC
    BLOOD, 2004, 104 (03) : 607 - 618
  • [30] Clinical applications of liquid biopsy in multiple myeloma
    Trudel, Suzanne
    Pugh, Trevor
    CLINICAL CANCER RESEARCH, 2020, 26 (11) : 18 - 18
12345